Financial Toxicity Related to Cancer Diagnosis and Tretment in Adolescents and Young Adults
Conditions
Brief summary
The FINCARE-Young study aims to investigate the extent and development of financial toxicity in adolescents and young adults with cancer. The primary purpose of this study is to assess the level of financial burden experienced during the acute phase of cancer treatment and after completion of therapy, and to analyze changes over time. In addition, the study seeks to identify sociodemographic, clinical, and socioeconomic factors associated with financial toxicity, as well as its impact on employment and social reintegration. By focusing on young adult cancer survivors, this study addresses an underexplored population and seeks to generate evidence to improve supportive care strategies and reduce long-term financial consequences of cancer.
Interventions
None listed
Sponsors
University Medical Center Goettingen
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No
Inclusion criteria
* Age 18 to 39 years at the time of initial cancer diagnosis * Diagnosis of a malignant neoplasm * Receipt of oncological treatment at the University Medical Center Göttingen * Completion of primary cancer therapy at the time of study participation * Initial diagnosis between 2014 and 2024 * Ability to provide informed consent * Sufficient German language skills to participate in a telephone interview and complete questionnaires
Exclusion criteria
* Age below 18 years or above 39 years at the time of initial cancer diagnosis * No history of malignant disease * Ongoing primary cancer treatment at the time of study participation * Severe cognitive impairment or psychiatric condition preventing reliable participation * Insufficient German language proficiency to complete interviews or questionnaires * Withdrawal of informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Financial toxicity | From the acute phase of cancer treatment to the time of study participation after completion of therapy (retrospective assessment of treatment period and current assessment at follow-up), assessed only at one time point at study enrollment. | Financial toxicity, assessed using the Comprehensive Score for Financial Toxicity (COST) questionnaire, measured during the acute phase of cancer treatment and at the time of study participation, including change over time. |
Countries
Germany
Outcome results
None listed